Here are six updates for medical device companies focused on spine and orthopedic procedures.
1. NuVasive received an average "buy" recommendation from 14 ratings firms, and four equities research analysts rating the stock with a "hold" and nine with a "buy." The average 12-month target price is $44.75, according to an InterCooler report.
2. LDR's CFO Robert McNamara sold 5,555 shares of company stock on Dec. 11 at an average price of $32 per share for a total transaction value of $177,760. He now owns 346 shares valued at $11,072, according to a Watch List News report.
3. K2M hit a 52-week high on Dec. 12 when the stock price peaked at $20.55. The stock opened at $19.85 and closed at $19.86 on Dec. 12. The company's 52-week high came on a volume of 130,857, according to an Equities report.
4. Medtronic received an average "buy" rating from 20 analysts covering the stock, with three rating a "hold" and 14 giving a "buy" rating. The company's average 12-month target price is $75.25, according to a report from The Legacy.
5. Smith & Nephew has "hold" consensus rating from ratings firms, with 10 giving "hold" recommendations and seven giving the company's stock a "buy rating. The average 12-month price target is $97, according to a Sleek Money report.
6. Stryker Director Ronda Stryker sold 21,000 shares of the company's stock on the open market on Dec. 11 at an average price of $93.50 for a total transaction value of $1.9 million. Ms. Stryker now directly owns 174,605, valued at $16.3 million, according to a Dakota Financial News report.